BioSpace News Archive

Policy

Biophytis has Requested a Pre-Submission Meeting with the FDA for an Emergency Use Authorization of Sarconeos (BIO101) for the Treatment of COVID-19

Biophytis SA announced that it has filed for a pre-submission meeting request with the Food and Drug Administration to discuss filing for Emergency Use Authorization in the United States for Sarconeos in the treatment of severe forms of COVID-19.

July 20, 2023
·
4 min read
Business

Sapreme Appoints Experienced Industry Executives, Dr. Jeanne Bolger and Dr. Andre Hoekema, to its Board of Directors

Sapreme, a biotechnology company focused on improving the delivery and efficacy of macromolecule therapeutics, announced the appointment of experienced biopharmaceutical industry executives Jeanne Bolger, MD, and Andre Hoekema, PhD, to its Board of Directors.

July 20, 2023
·
3 min read
Business

LimmaTech Biologics Appoints Franz-Werner Haas as CEO to Lead Company into Next Stage of Corporate Growth

LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of life-threatening diseases, announced the appointment of experienced biotechnology leader Franz-Werner Haas, LL.D., as its Chief Executive Officer.

July 20, 2023
·
3 min read
Neoss® Group signs a collaboration agreement with Osstell® AB

Neoss Group, a pioneer in dental implant solutions, is delighted to announce our partnership with Osstell AB, a global organization from Gothenburg, Sweden.

July 20, 2023
·
2 min read
Business

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Second Quarter of 2023

Genmab A/S announced that worldwide net trade sales of DARZALEX®, including sales of the subcutaneous product, as reported by Johnson & Johnson were USD 2,431 million in the second quarter of 2023.

July 20, 2023
·
3 min read
Business

Johnson & Johnson Reports Q2 2023 Results

Johnson & Johnson announced results for second-quarter 2023. “Our robust performance in the second quarter and first half of 2023 is a testament to the hard work and commitment of our colleagues around the world,” said Joaquin Duato, Chairman of the Board and Chief Executive Officer.

July 20, 2023
·
13 min read
Business

Teleflex Announces Second Quarter 2023 Earnings Conference Call Information

Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, August 3, 2023.

July 20, 2023
·
1 min read
Business

Karuna Therapeutics to Announce Second Quarter 2023 Financial Results and Provide General Business Update on Thursday, August 3, 2023

Karuna Therapeutics, Inc. announced that it will host a live conference call and webcast on Thursday, August 3, 2023 at 8:00 a.m. ET to review second quarter 2023 financial results and provide a general business update.

July 20, 2023
·
1 min read
Business

argenx to Report Half Year 2023 Financial Results and Second Quarter Business Update on July 27, 2023

argenx announced that it will host a conference call and audio webcast on Thursday, July 27, 2023 at 2:30 pm CET to discuss its half year 2023 financial results and provide a second quarter business update.

July 20, 2023
·
1 min read
Business

Verona Pharma to Report Second Quarter 2023 Financial Results and Provide Corporate Update

Verona Pharma plc, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the second quarter ended June 30, 2023 on Thursday, August 3, 2023 and host an investment community conference call at 9:00 a.m. EDT / 2:00 p.m.

July 20, 2023
·
2 min read